Compete for Investment Funds at the Rocky Mountain Life Science Investor & Partnering Conference
This year’s conference will be held in Vail, CO, October 2 and 3. The state biotech associations from CA, CO, AZ, MT, UT, as well as NMBio, are bringing together leading investors, emerging companies and senior executives to cultivate partnerships within our industry. The Rocky Mountain region is the largest and most advanced bioscience area between both coasts, with Colorado ranking in the top 10 among states for venture capital investment in the life sciences.
It is a rolling application process, and applications will be accepted until the July 28. The first round has closed. The second round closes on June 7. Companies are encouraged to apply early for consideration and will be notified of their presenting status no later than August 4. There is no charge to apply. In the interest of full disclosure, I’m participating on the selection committee so do NM and yourself proud and apply. Also, I’d like to encourage our members and community partners that are angel investors to attend and help brand NM as an emerging center for the biosciences.
Don’t miss this chance to participate in some of the newest deals and meet those who are shaping the future landscape of the life sciences industry. Additional informations and applications are available by connecting to the following link: http://www.cobioscience.com/events-calendar/RMLIPC2017
Investors from the 2015 conference included firms from throughout the country, including GlaxoSmithKline, Philadelphia, PA; MSV Ventures and Broadview Ventures, Boston, MA, Baird Capital and GE Healthcare Financial Services, Chicago, IL; H.I.G Capital and 5AM Ventures, Miami, FL; Medtronic, Minneapolis, MN; HealthQuest and Longitude Capital, Menlo Park, CA; KMG Capital, Denver, CO; and Teijin Pharma, Toyko, Japan. Here’s the complete list: http://www.cobioscience.com/RMLIPC/investors-2015